Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Currently in preclinical development, MaaT034 is a microbiome-based therapy designed to boost ICI efficacy in cancer treatment belonging to the MET-C (co-cultured) platform.
see also:
MaaT Pharma
Microbiome Ecosystem Therapies (MET) TM
…